
Janssen closes plant in California, 49 positions axed
pharmafile | April 3, 2019 | News story | Manufacturing and Production, Research and Development | J&J, JJ, Janssen, Johnson & Johnson, Vacaville, california
Janssen are letting go of 49 employees due to the closure of their plant in Vacaville, California.
The Johnson & Johnson subsidiary took over the plant in 2001, after the healthcare conglomerate acquired the Palo Alto-based ALZA Corporation for $10.5 billion.
However the permanent closure will see 49 workers lose their jobs, as Janssen announced their decision to close the Vacaville facility. The firm said that the plant was no longer needed due to a shift in focus towards other areas.
“As part of this transformation, we will scale down production at our Vacaville, California facility with the intent to fully exit the site by the end of 2022,” J&J spokesman Matthew Johnson said.
Louis Goss
Related Content

Johnson & Johnson commits $2bn to new manufacturing facility in North Carolina, US
Johnson & Johnson has announced a $2bn investment in a new manufacturing facility in Holly …

Johnson & Johnson submits FDA application for Caplyta to prevent schizophrenia relapse
Johnson & Johnson has submitted a supplemental New Drug Application to the US Food and …

Johnson & Johnson seeks EMA approval to accelerate prostate cancer treatment
Johnson & Johnson has submitted an application to the European Medicines Agency for an indication …






